Neuronetics Inc. (NASDAQ: STIM)
$0.8902
+0.0548 ( +5.35% ) 168.5K
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Market Data
Open
$0.8902
Previous close
$0.8354
Volume
168.5K
Market cap
$26.85M
Day range
$0.8330 - $0.9250
52 week range
$0.5200 - $5.0699
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Mar 28, 2024 |
8-k | 8K-related | 13 | Mar 25, 2024 |
10-k | Annual reports | 117 | Mar 08, 2024 |
8-k | 8K-related | 14 | Mar 06, 2024 |
8-k | 8K-related | 16 | Mar 05, 2024 |
8-k | 8K-related | 14 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 01, 2024 |
4 | Insider transactions | 1 | Mar 01, 2024 |
4 | Insider transactions | 1 | Feb 29, 2024 |
4 | Insider transactions | 1 | Feb 28, 2024 |